Page last updated: 2024-08-24

imiquimod and Freckle, Melanotic

imiquimod has been researched along with Freckle, Melanotic in 109 studies

Research

Studies (109)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	42 (38.53)	29.6817
2010's	43 (39.45)	24.3611
2020's	24 (22.02)	2.80

Authors

Authors	Studies
Fogarty, GB; Guitera, P; Hong, A; O'Donnell, BA; Paton, E; Pellacani, G; Scolyer, RA; Stretch, JR; Waddell, A	2
Brown, H; De'Ambrosis, B; Kennedy, D; Louie, B; McCormack, C; Muir, J; Smithers, BM	1
Álvarez-Chinchilla, P; Bañuls-Roca, J; Hispán-Ocete, P; Poveda-Montoyo, I; Schneller-Pavelescu, L	2
Daniel, C; Kaushik, M; Neumann, I; Patalay, R; Timlin, H	1
Bedane, C; Bens, G; Beylot-Barry, M; Bossard, C; Daude, M; Debarbieux, S; Denis, MG; Dinulescu, M; Dréno, B; Khammari, A; Le Duff, F; Leccia, MT; Legoupil, D; Machet, L; Maillard, H; Meyer, N; Monestier, S; Nguyen, JM; Vergier, B; Wierzbicka-Hainaut, E	1
Colombo, J; De Giorgi, V; Silvestri, F; Trane, L; Venturi, F; Zuccaro, B	1
Javed, MU; Kaur, A; Murison, M; Venables, B; Yarrow, J	1
Bowen, GM; Sampson, BP	1
Lam, M; Olabi, B; Patel, A; Smith, H; Varma, S; Veitch, D	1
Aw Yeang, HX; Behren, A; Caramia, F; Cebon, J; Halse, H; Haskett, M; Keam, SP; Ly, L; Mar, VJ; McArthur, GA; McLean, CA; Neeson, PJ; Wang, M	1
Guitera, P; Hong, A; Primiero, C; Robinson, M; Scolyer, RA; Soyer, HP; Stretch, JR; Strutton, G; Thompson, JF	1
Boyle, GM; Cullen, JK; Parsons, PG; Simmons, JL	1
Binic, I; Cantisani, C; Cantoresi, F; Golubovic, M; Marino, R; Mercuri, SR; Paolino, G	1
Griffiths, CC; Roman, EM; Wang, TS	1
Bartenjev, I; Bartenjev, MS; Isaković-Vidović, S	1
Lobo, Y; Templeman, R	1
Baker, C; Chambers, M; Chapman, MS; Saunders, E; Swetter, SM	1
Bossard, C; Denis Musquer, M; Dréno, B; Khammari, A; Nguyen, JM; Soenen, A; Vergier, B; Vourc'h, M	1
Apalla, Z; Argenziano, G; di Meo, N; Kittler, H; Kyrgidis, A; Lallas, A; Longo, C; Manoli, SM; Moscarella, E; Papageorgiou, C; Thomas, L; Zalaudek, I	1
Joyce, C; Kwak, R; Lin, JY; Tsibris, HC; Werchniak, AE	1
Guitera, P; Maher, NG	1
Hoekzema, R; Kirtschig, G; Tio, D; van Montfrans, C	1
Augustin, M; Dréno, B; Hoekzema, R; Prinsen, CAC; Tio, D; van Montfrans, C	1
Casanova, JM; García-de-la-Fuente, MR; Gatius, S; Huerva, V; Martí, RM; Matas-Nadal, C; Ortega, E; Sòria, X; Vilardell, F	1
Bowen, GM; Flores, S; Luby, NJ	1
Bowen, GM; Bowling, M; Donigan, JM; Goldgar, DE; Hadley, ML; Hyde, MA	1
Fosko, SW; Navarrete-Dechent, CP; Nehal, KS	1
Alfano, R; Argenziano, G; Corneli, P; DI Brizzi, EV; Donadio, C; Moscarella, E; Zalaudek, I	1
Astorino, S; Astorre, P; Di Nunno, D; Paolino, G; Pasquini, P; Pellegrini, F	1
Brand, FL; Hunger, RE; Seyed Jafari, SM	1
Lawrence, CM; Papanikolaou, M	1
DeWane, ME; Grant-Kels, JM; Kelsey, A; Oliviero, M; Rabinovitz, H	1
Bekkenk, MW; Hoekzema, R; Ruijter, CGH; Tio, DCKS; van Montfrans, C	1
Conforti, C; Di Meo, N; Giuffrida, R; Hamilko de Barros, M; Seabra Resende, FS; Zalaudek, I	1
Bassukas, IM; Gaitanis, G	1
Kirtschig, G; van Doorn, R; van Meurs, T	3
Alarcon, I; Alos, L; Carrera, C; Malvehy, J; Palou, J; Puig, S	1
Bratton, EM; Durairaj, VD; Gregory, DG; Knutsen-Larson, S; Mellette, JR	1
Apalla, Z; Chan, AW; Kyrgidis, A; Mocellin, S; Pilati, P; Tzellos, T	1
Chen, FW; Egbert, BM; Kim, DD; Swetter, SM	1
Karia, PS; Mora, AN; Nguyen, BM	1
David, M; Foote, M; Noonan, C; Read, T; Schaider, H; Smithers, BM; Soyer, HP; Wagels, M	1
Ahmad, K; Alani, A; Ramsay, B	1
Barlow, R; Coleman, A; Craythorne, EE; Kai, AC; Mallipeddi, R; Richards, T	1
Baumgartner, M; Gadaldi, K; Gautschi, M; Hunger, RE; Oberholzer, PA; Yawalkar, N	1
de Vries, K; Greveling, K; Prens, EP; van Doorn, MB	1
Billingham, LJ; Boota, NM; Cook, M; Fox, R; Marsden, JR; Steven, NM; Wheatley, K	1
Hoekzema, R; Jansma, EP; Prinsen, CAC; Tio, D; van der Woude, J; van Montfrans, C	1
Affleck, A; Hawkey, S	1
Braathen, LR; Buettiker, UV; Hunger, RE; Yawalkar, NY	1
Aguilar Bernier, M; Blázquez Sánchez, N; de Troya-Martín, M; Fernández-Canedo, NI; Frieyro-Elicegui, M; Fúnez Liébana, R	1
Joseph, MG; Mahoney, MH; Temple, C	1
Lacarrubba, F; Micali, G; Nardone, B; Nasca, MR	1
Ramsdell, AM; Zeitouni, N	1
Barlow, RJ; Powell, AM; Robson, AM; Russell-Jones, R	1
Walling, HW	1
McCall, MW; Woodmansee, CS	1
Junkins-Hopkins, JM	1
Busam, K; Marghoob, AA; Nadiminti, H; Nehal, KS; Scope, A	1
Cheikhrouhou, H; Claeys, A; Pouaha, J; Truchetet, F	1
Erickson, C; Miller, SJ	1
Bianciotto, CG; Demirci, H; Shields, CL; Shields, JA	1
Ayers, D; Kenealy, J; O'Neill, J	1
Bordeaux, JS; Capaldi, L; Maloney, ME; Martires, KJ; Pattee, SF	1
Chan, MP; Zimarowski, MJ	1
Botella-Estrada, R; Nagore, E	1
Choudhary, S; Giannakakis, G; McLeod, M; Nouri, K	1
Barbosa, VH; Beutner, KR; Bhushan, R; Bichakjian, CK; Chuang, TY; Duvic, M; Foote Hood, A; Grichnik, JM; Halpern, AC; Ho, VC; Johnson, TM; Smith Begolka, W; Sober, AJ; Swetter, SM; Tsao, H	1
García-Almagro, D; Lapresta, A; Sejas, AG	1
Byrne, M; Chamberlain, A; Curr, N; Dowling, JP; Haskett, M; Kelly, JW; Ly, L; O'Keefe, R; Sutton, T; Swain, S; Wolfe, R	1
Bowen, GM; Goldgar, D; Hadley, ML; Hyde, MA; Tristani-Firouzi, P	1
Guillén, C; Hilari, H; Llombart, B; Llorca, D; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V; Villanueva, A	1
de Vries, K; Habets, JM; Prens, EP; Rellum, R	1
Brennick, JB; Chapman, MS; Spencer, SK	1
Epstein, E	1
Fisher, GH; Lang, PG	1
Borucki, U; Metze, D	1
Cornelison, RL; Crowson, N; Garcia, C; Haque, R; Jankey, C; Kuwahara, R; Mackinnis, C; Naylor, MF; Odom, C; Teague, K	1
Barlow, RJ; Powell, AM; Russell-Jones, R	1
Powell, AM; Russell-Jones, R	1
Bryden, AM; Dawe, RS; Evans, A; Fleming, CJ; Ibbotson, SH	1
Huntley, A; Navi, D	1
Carre, JL; Guillet, G; Kupfer-Bessaguet, I; Leroy, JP; Misery, L; Sassolas, B	1
Braathen, LR; Brönnimann, M; Kappeler, A; Michalopoulos, P; Yawalkar, N	1
Skinner, R	1
Bauer, J; Eigentler, TK; Garbe, C; Kamin, A; Radny, P; Weide, B	1
Cerroni, L; Kerl, H; Kodama, K; Wolf, IH	2
Lorentzen, HF; Weismann, K	1
Bourguignon, R; Paquet, P; Piérard, GE; Quatresooz, P	1
Kunzle, N; Noel, B	1
Martín, T; Martínez, S; Ojeda, A; Vera, A	1
Wilson, LD	1
Fargnoli, MC; Micantonio, T; Peris, K	1
Marsden, JR; Rajpar, SF	1
Cornelison, R; Crowson, AN; Haque, R; Metcalf, S; Naylor, M	1
Beltrani, V; Brennick, JB; Chapman, MS; Perry, AE; Spenny, ML; Storm, CA; Walford, J; Werchniak, AE	1
du Plessis, PJ	1
Bernardino, CR; Murchison, AP; Soloman, AR; Washington, CV	1
Hopson, B; Richey, D; Sajben, FP	1
Bowen, GM; Cotter, MA; McKenna, JK	1
Bassukas, ID; Fotika, C; Gamvroulia, C; Nomikos, K; Zioga, A	1
Ahmed, I; Berth-Jones, J	1
Flowers, F	1

Reviews

18 review(s) available for imiquimod and Freckle, Melanotic

Article	Year
A practical guide on the use of imiquimod cream to treat lentigo maligna. The Australasian journal of dermatology, 2021, Volume: 62, Issue:4 Topics: Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2021
Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review. Eye (London, England), 2023, Volume: 37, Issue:3 Topics: Aminoquinolines; Eyelids; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Skin Neoplasms	2023
Evidence-Based Clinical Practice Guidelines for the Management of Patients with Lentigo Maligna. Dermatology (Basel, Switzerland), 2020, Volume: 236, Issue:2 Topics: Administration, Topical; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Margins of Excision; Microscopy, Confocal	2020
Topical treatments for skin cancer. Advanced drug delivery reviews, 2020, 01-01, Volume: 153 Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Diterpenes; Drug Delivery Systems; Fluorouracil; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis, Actinic; Melanoma; Neoplasms, Squamous Cell; Photochemotherapy; Retinoids; Skin; Skin Neoplasms; Ultraviolet Rays	2020
Melanoma on chronically sun-damaged skin: Lentigo maligna and desmoplastic melanoma. Journal of the American Academy of Dermatology, 2019, Volume: 81, Issue:3 Topics: B7-H1 Antigen; Biopsy; Dermatologic Surgical Procedures; Dermoscopy; Diagnosis, Differential; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunotherapy; Margins of Excision; Microscopy, Confocal; Mutation Rate; Neoplasm Invasiveness; Neurofibromin 1; Proto-Oncogene Proteins c-kit; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Skin; Skin Aging; Skin Neoplasms; Sunlight; Treatment Outcome	2019
Clinical usefulness of dermoscopy in the management of lentigo maligna melanoma treated with topical imiquimod: A case report. Dermatologic therapy, 2019, Volume: 32, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Aged, 80 and over; Combined Modality Therapy; Dermatologic Surgical Procedures; Dermoscopy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Preoperative Care; Prognosis; Risk Assessment; Skin Neoplasms; Treatment Outcome	2019
Interventions for melanoma in situ, including lentigo maligna. The Cochrane database of systematic reviews, 2014, Dec-19, Issue:12 Topics: Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Melanoma, Cutaneous Malignant; Nicotinic Acids; Randomized Controlled Trials as Topic; Skin Neoplasms	2014
A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance. Journal of the American Academy of Dermatology, 2015, Volume: 73, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Assessment; Skin Neoplasms; Survival Rate; Treatment Outcome	2015
A systematic review of non-surgical treatments for lentigo maligna. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:5 Topics: Adjuvants, Immunologic; Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy	2016
A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures. Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Skin Neoplasms	2017
Lentigo maligna: current concepts in diagnosis and management. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009, Volume: 144, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Cryotherapy; Curettage; Early Diagnosis; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2009
Imiquimod for superficial and in situ skin malignancy. Drug and therapeutics bulletin, 2009, Volume: 47, Issue:10 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Neoplasms	2009
Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery. International journal of dermatology, 2010, Volume: 49, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2010
[Imiquimod in the treatment of lentigo maligna]. Actas dermo-sifiliograficas, 2011, Volume: 102, Issue:8 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Contraindications; Cryotherapy; Disease Progression; Drug Approval; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Microscopy, Confocal; Mohs Surgery; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome	2011
Surgical treatments for lentigo maligna: a review. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011, Volume: 37, Issue:9 Topics: Aminoquinolines; Antineoplastic Agents; Cryosurgery; Curettage; Electrosurgery; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Laser Therapy; Mohs Surgery; Skin Neoplasms	2011
Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatology online journal, 2004, Jul-15, Volume: 10, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms	2004
Role of topical therapies in the management of cutaneous disease. Journal of cutaneous medicine and surgery, 2004, Volume: 8 Suppl 3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Dermatitis, Atopic; Dermatitis, Seborrheic; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Melanoma; Membrane Glycoproteins; Receptors, Cell Surface; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Toll-Like Receptors	2004
Imiquimod in the treatment of lentigo maligna. The British journal of dermatology, 2006, Volume: 155, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Interferon Inducers; Skin Neoplasms	2006

Trials

11 trial(s) available for imiquimod and Freckle, Melanotic

Article	Year
Efficacy of imiquimod in the management of lentigo maligna. Journal of the European Academy of Dermatology and Venereology : JEADV, 2023, Volume: 37, Issue:9 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms	2023
Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management. Journal of the American Academy of Dermatology, 2022, Volume: 86, Issue:5 Topics: Dermoscopy; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Microscopy, Confocal; Skin Neoplasms	2022
Twelve-week treatment of lentigo maligna with imiquimod results in a high and sustained clearance rate. Acta dermato-venereologica, 2015, Volume: 95, Issue:1 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Drug Administration Schedule; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Prospective Studies; Remission Induction; Skin Neoplasms; Time Factors; Treatment Outcome	2015
Prognostic markers in lentigo maligna patients treated with imiquimod cream: A long-term follow-up study. Journal of the American Academy of Dermatology, 2016, Volume: 74, Issue:1 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Biopsy, Needle; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Male; Melanocytes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Risk Assessment; Skin Cream; Skin Neoplasms; Switzerland; Time Factors; Treatment Outcome	2016
Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study. The British journal of dermatology, 2017, Volume: 176, Issue:5 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2017
Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients. Archives of dermatology, 2008, Volume: 144, Issue:7 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Face; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Skin Neoplasms; Treatment Outcome	2008
Efficacy of imiquimod cream, 5%, for lentigo maligna after complete excision: a study of 43 patients. Archives of dermatology, 2011, Volume: 147, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Emollients; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome; Young Adult	2011
A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions. Archives of dermatology, 2012, Volume: 148, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Cheek; Dermatologic Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Gels; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Mohs Surgery; Nicotinic Acids; Off-Label Use; Ointments; Postoperative Care; Prospective Studies; Skin Neoplasms; Treatment Outcome	2012
Treatment of lentigo maligna with topical imiquimod. The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Cytokines; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Ointments; Skin Ulcer; Treatment Outcome	2003
Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod. Archives of dermatology, 2005, Volume: 141, Issue:4 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Male; Pilot Projects; Risk Assessment; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2005
Imiquimod as an antiaging agent. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Cell Count; Collagen; Dermis; Drug Administration Schedule; Epidermis; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanins; Melanocytes; Ointments; Skin Aging; Skin Neoplasms	2007

Other Studies

80 other study(ies) available for imiquimod and Freckle, Melanotic

Article	Year
Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'. The Australasian journal of dermatology, 2022, Volume: 63, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2022
Reply to: A practical guide on the use of imiquimod cream to treat lentigo maligna. The Australasian journal of dermatology, 2022, Volume: 63, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2022
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences. Actas dermo-sifiliograficas, 2022, Volume: 113, Issue:4 Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2022
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences. Actas dermo-sifiliograficas, 2022, Volume: 113, Issue:4 Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2022
RECURRENT LENTIGO MALIGNA: CONSERVATIVE CONTINUOUS TREATMENT WITH IMIQUIMOD OR REPEATED SURGERY? A LONG-TERM FOLLOW-UP DERMOSCOPIC CASE STUDY. Experimental oncology, 2023, 06-26, Volume: 45, Issue:1 Topics: Aminoquinolines; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms	2023
Rate of recurrence following treatment of lentigo maligna with carbon dioxide laser alone or in combination with imiquimod: Results of a long-term study. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2023, Volume: 85 Topics: Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lasers, Gas; Longitudinal Studies; Neoplasm Recurrence, Local; Skin Neoplasms	2023
Strategies for Reducing Final Surgical Defect Sizes in the Treatment of Lentigo Maligna. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2020, Volume: 46, Issue:4 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Biopsy; Chemotherapy, Adjuvant; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Margins of Excision; Middle Aged; Neoplasm Staging; Retrospective Studies; Skin Neoplasms; Surgical Wound; Suture Techniques; Treatment Outcome	2020
Response to 'Long-term outcomes of imiquimod-treated lentigo maligna'. Clinical and experimental dermatology, 2020, Volume: 45, Issue:2 Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2020
A Distinct Pretreatment Immune Gene Signature in Lentigo Maligna Is Associated with Imiquimod Response. The Journal of investigative dermatology, 2020, Volume: 140, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; B7-H1 Antigen; Biopsy; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Skin Neoplasms	2020
Efficacy of imiquimod 3.75% cream for the treatment of solar lentigo. Dermatologic therapy, 2020, Volume: 33, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lentigo; Skin Neoplasms; Treatment Outcome	2020
Should topical imiquimod be used for positive margins in lentigo maligna? Journal of the American Academy of Dermatology, 2021, Volume: 85, Issue:2 Topics: Administration, Topical; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Margins of Excision; Skin Neoplasms	2021
Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ. Acta dermatovenerologica Croatica : ADC, 2020, Volume: 28, Issue:1 Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2020
Conservative treatment of lentigo maligna with topical imiquimod 5% cream: a case report. Dermatology online journal, 2020, Jul-15, Volume: 26, Issue:7 Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Agents; Conservative Treatment; Drug Administration Schedule; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Nausea; Skin Neoplasms; Vomiting	2020
Topical Imiquimod for Lentigo Maligna: Survival Analysis of 103 Cases With 17 Years Follow-up. Journal of drugs in dermatology : JDD, 2021, 03-01, Volume: 20, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratolytic Agents; Male; Middle Aged; Neoplasm Recurrence, Local; Nicotinic Acids; Prospective Studies; Retrospective Studies; Skin Neoplasms; Time Factors	2021
Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna. The British journal of dermatology, 2021, Volume: 185, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Off-Label Use; Skin Neoplasms	2021
Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment. The Journal of dermatological treatment, 2022, Volume: 33, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Margins of Excision; Skin Neoplasms; Treatment Outcome	2022
Imiquimod treatment for lentigo maligna: LIMIT-1 trial. The British journal of dermatology, 2017, Volume: 177, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lentigo; Skin Neoplasms	2017
Lymphoedema in patients with lentigo maligna treated with imiquimod: a long-term adverse effect. The British journal of dermatology, 2018, Volume: 178, Issue:6 Topics: Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lymphedema; Skin Neoplasms	2018
Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members. Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:9 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Cryotherapy; Dermatologic Surgical Procedures; Dermatology; Dermoscopy; Europe; Female; Health Care Surveys; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Patient Preference; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiotherapy; Skin Neoplasms; Watchful Waiting	2018
Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma. The Journal of dermatology, 2018, Volume: 45, Issue:5 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Biopsy; Combined Modality Therapy; Cryosurgery; Dermatologic Surgical Procedures; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunotherapy; Melanoma; Skin; Skin Cream; Skin Neoplasms	2018
Comparison of Melanocyte Density Counts in Topical Imiquimod-Treated Skin Surrounding Lentigo Maligna vs Control Biopsy Specimens. JAMA dermatology, 2018, 04-01, Volume: 154, Issue:4 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Biopsy; Cell Count; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanocytes; Skin; Skin Neoplasms	2018
Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision. JAMA dermatology, 2018, 08-01, Volume: 154, Issue:8 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Nicotinic Acids; Off-Label Use; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2018
Lentigo Maligna-Challenges, Observations, Imiquimod, Confocal Microscopy, and Personalized Treatment. JAMA dermatology, 2018, 08-01, Volume: 154, Issue:8 Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Microscopy, Confocal; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Off-Label Use; Skin Neoplasms	2018
Serial excision and imiquimod for lentigo maligna melanoma: a proposal for a combined treatment. Italian journal of dermatology and venereology, 2021, Volume: 156, Issue:Suppl. 1 t Topics: Combined Modality Therapy; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Skin Neoplasms	2021
Imiquimod 5% cream in occlusion, for the treatment of lentigo maligna: A new scheme of short cycles and the need for clinical trials. Dermatologic therapy, 2019, Volume: 32, Issue:1 Topics: Administration, Cutaneous; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms; Time Factors; Treatment Outcome	2019
Confocal Microscopy and Lentigo Maligna: An in vivo Pilot Study for the Assessment of Response to Imiquimod Therapy. Dermatology (Basel, Switzerland), 2019, Volume: 235, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Contraindications, Procedure; Dermatologic Surgical Procedures; Dermoscopy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Skin Neoplasms; Treatment Outcome	2019
Long-term outcomes of imiquimod-treated lentigo maligna. Clinical and experimental dermatology, 2019, Volume: 44, Issue:6 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Biopsy; Dose-Response Relationship, Drug; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Inflammation; Male; Middle Aged; Pigmentation; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2019
Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment. Acta dermato-venereologica, 2019, Sep-01, Volume: 99, Issue:10 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Off-Label Use; Remission Induction; Retrospective Studies; Skin Neoplasms; Time Factors; Treatment Outcome; Young Adult	2019
Long-term outcomes of imiquimod-treated lentigo maligna: add on cryosurgery to induce inflammation and increase efficacy? Clinical and experimental dermatology, 2020, Volume: 45, Issue:2 Topics: Cryosurgery; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Inflammation; Melanoma; Skin Neoplasms	2020
In vivo reflectance confocal microscopy to monitor the response of lentigo maligna to imiquimod. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:1 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Dermoscopy; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Off-Label Use; Prospective Studies; Skin Neoplasms	2014
Combination topical therapy for conjunctival primary acquired melanosis with atypia and periocular lentigo maligna. Cornea, 2015, Volume: 34, Issue:1 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Conjunctival Diseases; Cryotherapy; Eyelid Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Interferon alpha-2; Interferon-alpha; Melanosis; Recombinant Proteins	2015
Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type. Journal of the American Academy of Dermatology, 2015, Volume: 72, Issue:6 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma in Situ; Chemotherapy, Adjuvant; Cohort Studies; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Risk Assessment; Skin Cream; Skin Neoplasms; Survival Rate; Treatment Outcome	2015
Diagnosis of Amelanotic Lentigo Maligna by Using In vivo Reflectance Confocal Microscopy. Acta dermato-venereologica, 2016, Volume: 96, Issue:3 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Cell Proliferation; Epidermis; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanocytes; Melanoma, Amelanotic; Microscopy, Confocal; Predictive Value of Tests; Skin Neoplasms; Treatment Outcome	2016
Five-year recurrence rate of lentigo maligna after treatment with imiquimod. The British journal of dermatology, 2016, Volume: 174, Issue:1 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms	2016
A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose. The British journal of dermatology, 2016, Volume: 174, Issue:5 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy; Leg; Male; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms; Treatment Outcome	2016
Diagnosis and management of lentigo maligna: an observational study comparing 2005 with 2014 data in one institution. Clinical and experimental dermatology, 2017, Volume: 42, Issue:3 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Female; Hospitals, University; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Incidence; Male; Middle Aged; Radiotherapy; Retrospective Studies; Skin Neoplasms; Surgical Procedures, Operative; Watchful Waiting	2017
Lentigo maligna managed with topical imiquimod and dermoscopy: report of two cases. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:11 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Dermoscopy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Skin Neoplasms	2008
Topical imiquimod therapy for lentigo maligna. Annals of plastic surgery, 2008, Volume: 61, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Skin Neoplasms	2008
Videodermatoscopy of lentigo maligna treated with imiquimod. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:11 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Dermoscopy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Nose; Skin; Skin Neoplasms	2008
Long-term follow-up of a hemifacial lentigo maligna treated using 5% imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:2 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Disease-Free Survival; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Remission Induction; Skin Neoplasms	2009
Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up. The British journal of dermatology, 2009, Volume: 160, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Prognosis; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2009
Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:8 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Skin Neoplasms	2009
Imiquimod use in the treatment of lentigo maligna. Journal of the American Academy of Dermatology, 2009, Volume: 61, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Treatment Outcome	2009
Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:2 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Cryosurgery; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Microscopy, Confocal; Middle Aged; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome	2010
[Topical imiquimod as palliative therapy for extensive lentigo maligna on the cheek]. Annales de dermatologie et de venereologie, 2010, Volume: 137, Issue:2 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Cheek; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Palliative Care; Skin Neoplasms	2010
Topical imiquimod for periocular lentigo maligna. Ophthalmology, 2010, Volume: 117, Issue:12 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Eyelid Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms	2010
Treatment of lentigo maligna with imiquimod cream: a long-term follow-up study of 10 patients. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:6 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome	2010
Periocular lentigo maligna treated with imiquimod. The Journal of dermatological treatment, 2011, Volume: 22, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Eye Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2011
Failed treatment of amelanotic lentigo maligna with imiquimod followed by pigment production. Archives of dermatology, 2010, Volume: 146, Issue:9 Topics: Administration, Topical; Aminoquinolines; Biopsy, Needle; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Melanoma, Amelanotic; Middle Aged; Neoplasm Recurrence, Local; Nose; Risk Assessment; Skin Neoplasms; Treatment Outcome	2010
Lupus erythematosus-like reaction in imiquimod-treated skin: a report of 2 cases. The American Journal of dermatopathology, 2011, Volume: 33, Issue:5 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Dermatitis; Diagnosis, Differential; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis, Actinic; Lupus Erythematosus, Systemic; Male; Skin Neoplasms	2011
Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Asymptomatic Diseases; Cryotherapy; Diagnostic Imaging; Evidence-Based Medicine; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lymphatic Metastasis; Melanoma; Nail Diseases; Neoplasm Grading; Neoplasm Staging; Sentinel Lymph Node Biopsy; Skin Neoplasms	2011
Amelanotic lentigo maligna managed with topical imiquimod. The Journal of dermatology, 2012, Volume: 39, Issue:5 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma, Amelanotic; Skin Neoplasms	2012
Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:7 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Paraffin Embedding; Reoperation; Retrospective Studies; Skin Neoplasms; Skin Pigmentation; Treatment Outcome	2012
A novel two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod. The British journal of dermatology, 2013, Volume: 168, Issue:6 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2013
Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream. Archives of dermatology, 2003, Volume: 139, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms	2003
Extensive lentigo maligna clearing with topical imiquimod. Archives of dermatology, 2003, Volume: 139, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2003
Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Archives of dermatology, 2003, Volume: 139, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Skin Neoplasms	2003
Topical treatment of lentigo maligna melanoma with imiquimod 5% cream. Dermatology (Basel, Switzerland), 2003, Volume: 207, Issue:3 Topics: Administration, Topical; Aged; Aminoquinolines; Dose-Response Relationship, Drug; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Ointments; Skin Neoplasms; Treatment Outcome	2003
Topical imiquimod immunotherapy in the management of lentigo maligna. Clinical and experimental dermatology, 2004, Volume: 29, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunotherapy; Male; Skin Neoplasms; Treatment Outcome	2004
Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy. Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:5 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Ointments; Skin Neoplasms	2004
A pilot study of treatment of lentigo maligna with 5% imiquimod cream. The British journal of dermatology, 2004, Volume: 151, Issue:2 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Pilot Projects; Skin Neoplasms; Treatment Outcome	2004
Topical imiquimod treatment of lentigo maligna: clinical and histologic evaluation. Journal of the American Academy of Dermatology, 2004, Volume: 51, Issue:4 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Drug Administration Schedule; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Skin; Skin Neoplasms; Treatment Outcome	2004
Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod. The British journal of dermatology, 2004, Volume: 151, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms; T-Lymphocyte Subsets	2004
Imiquimod in the treatment of extensive recurrent lentigo maligna. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:2 Suppl 1 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Recurrence, Local; Skin Neoplasms	2005
[Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance]. Ugeskrift for laeger, 2005, Sep-26, Volume: 167, Issue:39 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Cheek; Dermoscopy; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Ointments; Skin Neoplasms	2005
[How I treat ... lentigo maligna by topical imiquimod]. Revue medicale de Liege, 2005, Volume: 60, Issue:9 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms	2005
Image in clinical medicine. Lentigo maligna. The New England journal of medicine, 2005, Nov-17, Volume: 353, Issue:20 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Face; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Ointments; Skin Neoplasms	2005
[Lentigo maligna treated with 5% imiquimod cream]. Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:10 Topics: Aminoquinolines; Antineoplastic Agents; Dosage Forms; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Remission Induction; Skin Neoplasms	2005
Lentigo maligna and radiotherapy. The New England journal of medicine, 2006, Mar-23, Volume: 354, Issue:12 Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2006
Usefulness of dermoscopy to monitor clinical efficacy of imiquimod treatment for lentigo maligna. Archives of dermatology, 2006, Volume: 142, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Cheek; Dermoscopy; Disease Progression; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin Neoplasms	2006
Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 case reports. Cutis, 2007, Volume: 79, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Ointments; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2007
Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Forehead; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms	2007
Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment. The American Journal of dermatopathology, 2007, Volume: 29, Issue:3 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Biomarkers, Tumor; Bowen's Disease; Carcinoma in Situ; Carcinoma, Basal Cell; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Inflammation; Keratosis; Male; Melanoma; Middle Aged; Skin Neoplasms	2007
Lentigo maligna successfully treated with imiquimod. South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie, 2007, Volume: 45, Issue:2 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Cryotherapy; Forehead; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Reoperation; Skin Neoplasms; Treatment Outcome	2007
Ocular effects of imiquimod with treatment of eyelid melanoma in situ. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:9 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Conjunctiva; Erythema; Eyelid Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin; Skin Neoplasms; Visual Acuity	2007
Treatment of lentigo maligna with imiquimod 5% cream. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:10 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms	2007
Treatment of lentigo maligna with imiquimod before staged excision. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:2 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Ointments; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2008
Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna. International journal of dermatology, 2008, Volume: 47, Issue:5 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Combined Modality Therapy; Cryosurgery; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Skin Neoplasms	2008
Imiquimod: a novel treatment for lentigo maligna. The British journal of dermatology, 2000, Volume: 143, Issue:4 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Interferon Inducers; Male; Scalp; Skin Neoplasms	2000
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms. International journal of dermatology, 2002, Volume: 41 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Bowen's Disease; Cicatrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis; Paget Disease, Extramammary; Photochemotherapy; Pruritus; Randomized Controlled Trials as Topic; Skin Neoplasms	2002